US Patent Granted for Galidesivir in filoviridae viruses
Filed with ASX · · 2 pages · English
Island Pharmaceuticals Ltd on 6ix
Story so far
Earlier from Island Pharmaceuticals
- Ongoing engagement with the US FDA
- Agreement with Texas Biomed for Galidesivir Program
- Island expands Galidesivir IP with US Patent Grant
- Additional FDA Submission completed for Galidesivir
- Options exercised raises $1million
Later from Island Pharmaceuticals
- Quarterly Appendix 4C and Activities Report
- FDA confirms Galidesivir approval pathway
- $9m placement to advance US biodefence opportunity
- Response to ASX Query Letter
- Appendix 4D & Half-Year Financial Statements
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals